Wearable Sensor for Responsive DBS for ET
Public ClinicalTrials.gov record NCT03051178. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Wearable Sensor Driven Closed-loop Deep Brain Stimulation for Essential Tremor
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is evaluate the effectiveness and safety of a possible new treatment for Essential Tremor (ET) using external wearable sensors, which have the capability of recording acceleration and Electromyography (EMG). This therapy is called Responsive Deep Brain Stimulation (R-DBS). R-DBS systems will communicate with a computer, and apply stimulation when the computer detects patterns associated with tremor. This detection will suppress pathological activity and improve or alleviate the tremor. Currently, DBS is approved for the treatment of ET; however, stimulation is delivered continuously even when tremor or other symptoms are absent. Continuous DBS can lead to unwanted side effects such as stuttering and gait\\balance problems. On the other hand, R-DBS will turn on only if activity associated with ET from the external sensors is detected.
Study identification
- NCT ID
- NCT03051178
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 17 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 17, 2018
- Primary completion
- Sep 28, 2021
- Completion
- Sep 28, 2021
- Last update posted
- Apr 18, 2024
2018 – 2021
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UF Health | Gainesville | Florida | 32610 | — |
| Biomedical Sciences Building | Gainesville | Florida | 32611 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Essential Tremor trials
Other public records listing Essential Tremor. Sorted by last update posted; newest first. Not a recommendation.
- NCT07721272: Human Cognition During Surgery: Stimulation-based and Cholinergic Modulation Not yet recruiting
- NCT06087276: Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET) Active, not recruiting
- NCT07599592: Open Label Study for the Use of Low Intensity Focused Ultrasound for Essential Tremor Recruiting
- NCT05897775: Coordinated Reset Deep Brain Stimulation for Essential Tremor Recruiting
- NCT06293638: Functional Brain Network Changes in Patients Undergoing Deep Brain Stimulation for Essential Tremor Recruiting
- NCT03664609: Deep Brain Stimulation (DBS) Retrospective Outcomes Study Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03051178, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 18, 2024 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03051178 live on ClinicalTrials.gov.